chrisvoncsefalvay/vaers-outcomes huggingface dataset:
psoriasis lesions that would disappear after 1 application of clobetesol foam/I had a flare-up which spread to every part of my body; This is a spontaneous report from a contactable consumer (patient). A 70-years-old non pregnant female patient received second dose of bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, solution for injection, Lot number: EL9267), via an unspecified route of administration in arm left on 18Feb2021 at 09:15 (at the age of 70-years-old) as single dose for COVID-19 immunisation. Medical history included blood cholesterol increased and psoriasis. Concomitant medication included atorvastatin calcium, loperamide hydrochloride, psyllium husk [plantago ovata husk]. The patient previously took macrodantin and experienced drug hypersensitivity, the patient previously received first dose of bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, solution for injection, Lot number: not reported), via an unspecified route of administration on an unknown date as single dose for COVID-19 immunisation. The patient was not pregnant at time of vaccination. The patient was not received any other vaccines within 4 weeks prior to the COVID vaccine. The patient was not having COVID prior vaccination and has not been COVIDtested post vaccination. For 40 years patient have had very occasional (less than 3 times a year) single location (less than 2 inches square) psoriasis lesions that would disappear after 1 application of clobetesol foam. 2 weeks after the 2nd jab on 01Mar2021 patient had a psoriasis flare-up which spread to every part of her body. Adverse event resulted in doctor or other healthcare professional office/clinic visit. patient received phototherapy as treatment for event. The outcome of the event was recovering.  Follow-Up (02Sep2021): Follow-up attempts are completed. No further information is expected.
Headache Sore Throat Stomachache Low Appetite Lethargy Aural Temperature of 101.5 Fahrenheit
This case was reported by a physician and described the occurrence of mercury poisoning in an adult female patient who received hepatitis B vaccine recombinant. The reporter is the patient. The physician submitted a report directly to VAERS. On an unspecified date in 1998, the patient received the first dose of Engerix B (lot # ENG2123A2). At an unspecified time later, on an unspecified date in 1998, the patient received the second dose of Engerix B (lot # ENG2004A2). At an unspecified time later, on an unspecified date in 1998, the patient received the third dose of Engerix B (lot # ENG2235A2). At an unspecified time following the third dose of Engerix B on or before 3/14/05, the patient experienced mercury poisoning that was described as mercury from the vaccine eating away her brain. The reporter stated that she was disabled for this event. This event was reported to GSK through the litigation process, or is in the litigation process. Additional information regarding the event will be reported it obtained.
0840: Pt c/o feeling "woozy." Pt laid back on exam table. Other staff notified. VS's taken: B/P 90/49, HR:79, R-14, O2 Sat 93%. Ice pack applied to forehead/neck. Pt stated felt flush, was warm to touch but pale pallor. Monitored. 0850: VS's B/P 98/66, HR:88, R: 18, O2 Sat: 96. Color Returning Pt. instructed to slowly stand with assistance. Mom and pt went to pharmacy NCOIC checked on pt at 0910. Pt c/o blurry vision in right eye only. Noted pt had been rubbing that eye during episode. Mom and pt returned from pharmacy at 0930. Mom and pt both stated pt was fine. Released from clinic with instructions of any further episodes to seek medical attention.
arm was slightly sore; This spontaneous case was reported by a consumer and describes the occurrence of PAIN IN EXTREMITY (arm was slightly sore) in a 75-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 032M20A and 016M20A) for COVID-19 vaccination.     Concomitant products included ATORVASTATIN for Cholesterol, OMEPRAZOLE for GERD.   On 05-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 05-Mar-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On an unknown date, the patient experienced PAIN IN EXTREMITY (arm was slightly sore). At the time of the report, PAIN IN EXTREMITY (arm was slightly sore) outcome was unknown.            No Treatment information provided    This case was linked to MOD-2021-013746 (Patient Link).
Sore arm Thursday until Sunday morning. Minor headache Saturday afternoon. Diarrhea Sunday evening.
I broke out in hives all over my upper body - neck, chest, breast, stomach and back.
Pt received vaccine on 7/8/16 and afterward experienced severe HA and fever approximately 101.5 for several days, unrelieved with ibuprofen or EXCEDRIN. Non N/V/D or neck stiffness. Hx migraine HAs. Pt called in for advice and was told to take sumatriptan and lie down. This resolved his HA. Pt also came in for arm redness assessment. He was going out of town and was given cephalexin in case of worsening redness to prevent soft tissue infection. Unclear whether he took it.
Immediately post injection noted that patient had gone flaccid for 3-5 seconds, possibly fainted,  then regained consciousness. Prior to receiving vaccine patient was visibly distraught, anxious and verbally expressed his fear of needles and vaccines.  No change in pallor,  breathing, or awareness noted. Patient was able to stabilize and maintained stability throughout observation period. No further signs or symptoms of distress noted. When nurse noted that patient had gone flaccid asked mom if he is okay, or if this is normal. Mom stated that she thinks he was being dramatic/pretending and did not recognize that he had gone flaccid for a few seconds.
I had a fever, body aches, headache, and loose stool. I contacted my doctor, and I was not prescribed medication. I tested negative for COVID-19 twice. This lasted for about 4 days.
Client received Janssen covid-19 vaccine on 05/05/2021.  The dose received was drawn up on 05/04/2021 around 2:20 p.m and should have been wasted at the end of the day on 05/04/2021 but it was not.  Dose was given on 05/05/2021 around 1:30 p.m. Unknown stability of the vaccine after 6 hours of being drawn up. Client did not present with any complications during the 15 minute waiting period.
Patient presented to the pharmacy after having what started as itching which led to redness and swelling and heat in the rash area which started the day after the vaccine.
The patient received a moderna vaccine originally and then received a pfizer vaccine as her second dose. No adverse reaction was notated.
Psoriasis, Lichen Planus, Joint Pain, Insomnia, Migraines, Degenerative Joint & Disc Disease, Indeterminate Cell Histiocytosis (ICH), Chronic Lymphocytic Leukemia. Treatments every other day for ICH using Narrow Band UvB radiation therapy.
Had a sore throat, cough and fever; Had a telehealth appointment and was advised to go to the local medical center emergency room; Was tested for the Flu, RSV and COVID-19; Was positive for COVID-19; Prescribed acetaminophen and codeine phosphate; zinc from sulfate 50mg; vitamin D3 and albuterol sulfate inhaler; Works in medical field and had to go to their outpatient clinic to confirm results; Quarantined and rested; Was given clearance to go back to work 10 days later; Still has lingering cough.
Discomfort at injection site with small lump present, more noticable with pressure (IE following side sleeping); Discomfort at injection site with small lump present, more noticable with pressure (IE following side sleeping); Pain throughout arm for 2-3 days; This is a spontaneous report from a contactable consumer, the patient. A 42-year-old non-pregnant female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EN5318) via an unspecified route of administration in the left arm on an unknown date in 2021 (at the age of 42-years-old) as a single dose for COVID-19 immunisation. Medical history included arthritis, scoliosis, pain, headache and chronic sinus. The patient had known allergies to wasp sting and codeine. Concomitant medications included PRN for pain and headache, taken on an unknown date, unknown if ongoing. The patient previously received first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EL3248) via an unspecified route of administration in the left arm on 06Jan2021 (at the age of 42-years-old) as a single dose for COVID-19 immunisation. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccines within four weeks prior to the COVID vaccine. Since the vaccination, the patient had been tested for COVID-19. On an unknown date in 2021, for second dose, the patient experienced pain throughout arm for 2-3 days, discomfort at injection site with small lump present, more noticeable with pressure (IE following side sleeping). It was reported that for first dose no adverse reactions. The events did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. No therapeutic measures were taken as a result of reported events. On 22Jun2021, the patient underwent rapid test (nasal Swab) and the result was negative. The clinical outcome of the events pain throughout arm for 2-3 days, discomfort at injection site with small lump present, more noticeable with pressure (IE following side sleeping) were resolving at the time of report.  No follow-up attempts are needed. No further information is expected.
Information has been received from a nurse practitioner concerning a patient who was vaccinated with a second dose of Rotateq. The patient was late for the second dose. The patient presented to the office later than 10 weeks post dose 1. The patient had no adverse experienced to report. Unspecified medical attention was sought. There was no product quality complaint involved. Additional information is not expected.
Patient received adult pneumonia 23-valent on 7/5/11. Patient reported on 7/6/11 patient noted increased pain in arm, swelling down arm to elbow, patient felt feverish. Treated symptomatically with TYLENOL, warm packs, ice packs with complete resolution of symptoms. Patient had received pneumonia 23 5/7/08 without problems.
Pt came to ER c/o loss of sense of taste, mild sore throat, onset 3 days ago.
Subsequent to receiving one dose of varicella virus vaccine live the pt experienced mild chickenpox with a mild rash with less than 50 lesions.
This spontaneous case reported by a consumer, describes the occurrence of malaise (feeling off), nervousness (legs felt shaky), influenza-like illness (mild case of the flu), fatigue (exhaustion) and headache in an 80-year-old female patient who received mRNA-1273 (Moderna COVID-19 vaccine, batch# 024M20A) for COVID-19 immunization. The occurrence of additional events detailed below. No medical history reported. On Feb 18, 2021, patient received the first dose of mRNA-1273 (Moderna COVID-19 vaccine), intramuscular; 1 dosage form. On Feb 18, 2021, patient experienced malaise (feeling off), nervousness (legs felt shaky), influenza-like illness (mild case of the flu), fatigue (exhaustion), headache and fatigue (extreme fatigue). On Feb 25, 2021, malaise (feeling off), nervousness (legs felt shaky), influenza-like illness (mild case of the flu), fatigue (exhaustion), headache and fatigue (extreme fatigue) resolved. The action taken with mRNA-1273 (Moderna COVID-19  vaccine), intramuscular: unknown. The reporter did not provide any causality assessments. The consumer is later scheduled to receive the second dose of the Moderna COVID-19 vaccine on Mar 18, 2021. Concomitant medications not provided. Treatment information included Tylenol and Motrin (self medicating). Most recent follow-up information incorporated above included: On May 4, 2021: Non-significant follow-up (contact information updated).
pt very fussy w/prolonged crying 3-4 hrs (?) p/vax; pt was overly tired & limp for the subsequent 12-16 hrs & did not feed for > 18 hrs;
This spontaneous report was received from a healthcare professional and refers to 2 patients of unknown age and gender. The patients' current conditions, medical history and concomitant medications were not reported. On unknown dates, the patients were vaccinated with improperly stored (Merck) VARIVAX doses (2 doses) (lot# L029472, expiry date 06-AUG-2017) (temperature: 9.3 Fahrenheit (F), time frame: 3.5 hours and data logger) (incorrect storage of drug). There was no previous temperature excursion. No adverse effects were reported. Product quality complaint (PQC) was not involved. No additional information was provided. Additional information has been requested.
This case was reported by a other health professional via sales rep and described the occurrence of injection site lump in a adult female patient who received SHINGRIX (batch number 7X3EJ, expiry date 13th October 2020) for prophylaxis. On an unknown date, the patient received SHINGRIX. On an unknown date, less than a year after receiving SHINGRIX, the patient experienced injection site lump, injection site pain, injection site warmth, injection site erythema and injection site swelling. On an unknown date, the outcome of the injection site lump, injection site pain, injection site warmth, injection site erythema and injection site swelling were unknown. It was unknown if the reporter considered the injection site lump, injection site pain, injection site warmth, injection site erythema and injection site swelling to be related to SHINGRIX. Additional details were provided as follows: This case was reported by a Clinical Coordinator. The age at vaccination was not reported. The patient had severe adverse reaction which was described as an egg-sized lump and extreme pain, the area was hot, red and swollen.
Spotting during ovulation for 4 days. I have never had spotting during ovulation before that I know of. I had one abnormally short light period in May 2017 that may have been ovulation bleeding. Otherwise it has never happened until after the covid vaccine.  I have had ovulation bleeding every cycle since I have gotten the vaccine. It lasted one day the next cycle and 4 days the cycle after.
High fever of 104, seizure, fast heart beat, hoarseness between 3:00-4:00AM Tuesday 11/19/02. Rushed to hospital.
This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP) for a Pfizer sponsored program. A male patient received bnt162b2 (BNT162B2) (Batch/Lot number: unknown) as dose number unknown, single for Covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. The following information was reported: PLATELET COUNT DECREASED (non-serious), outcome "unknown", described as "Routing bloodwork shortly after revealed platelets had crashed/ her father in withheld had same experience". Relevant laboratory tests and procedures are available in the appropriate section.- Additional information: Patient is still battling even after receiving platelet boosting meds. No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.
36 hour fever starting on 12/7/20, full body rash starting on 12/10/20, not yet resolved, joint aches (?) starting 12/10/20 not yet resolved
L arm swollen size of fist. red, and hot. No fever or noted swollen nodes in armpit
cold; runny nose; constant coughing; clots of blood coming out; a lot of tiredness; sick; Headache; This spontaneous case was reported by a consumer (subsequently medically confirmed) and describes the occurrence of NASOPHARYNGITIS (cold), RHINORRHOEA (runny nose), COUGH (constant coughing), HAEMOPTYSIS (clots of blood coming out) and FATIGUE (a lot of tiredness) in a 60-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 026A21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     The patient's past medical history included Multiple myeloma.    On 17-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 18-Mar-2021, the patient experienced NASOPHARYNGITIS (cold), RHINORRHOEA (runny nose), COUGH (constant coughing), HAEMOPTYSIS (clots of blood coming out), FATIGUE (a lot of tiredness), ILLNESS (sick) and HEADACHE (Headache). On 02-Apr-2021, NASOPHARYNGITIS (cold), RHINORRHOEA (runny nose), COUGH (constant coughing), HAEMOPTYSIS (clots of blood coming out), FATIGUE (a lot of tiredness), ILLNESS (sick) and HEADACHE (Headache) had resolved. Not Provided    DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On an unknown date, Computerised tomogram: normal Normal. On an unknown date, Ultrasound scan: normal Normal.     mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was withdrawn on an unknown date.       Patient had a past history of cancer(multiple myeloma) and was cancer free for 6 years. Treatment included antibiotics.   Most recent FOLLOW-UP information incorporated above includes: On 26-Apr-2021: Events added
This spontaneous report as received from an 80 year old male patient with high blood pressure and back problems refers to himself. The patient had no drug reactions/allergies. The patient stated that when he was a child, after receiving vaccinations like Whooping Cough, he developed scar tissue at the site of injection. On an unspecified date of 2011 (reported as "almost 3 years ago") the patient was vaccinated at a local pharmacy (specific contact information unspecified) with ZOSTAVAX (lot #, dose, route and frequency were not provided). Other suspect therapies included hydrocodone (manufacturer unspecified). Concomitant therapies included ALEVE, TYELNOL, PEPCID and high blood pressure medicine (unspecified). Patient also stated that for the last few years about every 6 months he receives a steroid shot directly in his lower back due to back problems and that he was currently receiving this medication when he received ZOSTAVAX. On an unspecified date of 2014 (reported as "almost 2 years later this past spring") the patient developed a non-itchy, red, blotchy rash that looked like pimples on the back of his upper arm and between his legs. The patient also reported that right before the rash developed he hurt his back and needed to be placed on unspecified muscle relaxers and hydrocodone. No lab diagnostics studies were performed. The patient didn't seek for medical attention. No treatment was given for the adverse events. The rash resolved soon after on its own. The patient reported he only developed the rash once he was on these additional medications and stated he believed he developed the rash due to the hydrocodone. Causality assessment between ZOSTAVAX and the adverse events was not provided by the reporter. Additional information has been requested.
Discovered with CT scan , admitted to hospital, placed on Apixaban  10 mg twice a day for  one month then  5 mg twice a day foe three months then back to Plavix.  Outcome unkown.
shooting/excruciating pain in her left leg muscle.; can't walk; pain has been shooting/excruciating; This spontaneous case was reported by a consumer and describes the occurrence of PAIN IN EXTREMITY (shooting/excruciating pain in her left leg muscle.), GAIT DISTURBANCE (can't walk) and PAIN (pain has been shooting/excruciating) in a 92-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On 09-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 09-Feb-2021, the patient experienced PAIN IN EXTREMITY (shooting/excruciating pain in her left leg muscle.), GAIT DISTURBANCE (can't walk) and PAIN (pain has been shooting/excruciating). The patient was treated with PARACETAMOL (TYLENOL) for Pain in leg, at an unspecified dose and frequency. At the time of the report, PAIN IN EXTREMITY (shooting/excruciating pain in her left leg muscle.), GAIT DISTURBANCE (can't walk) and PAIN (pain has been shooting/excruciating) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No relevant concomitant medications were reported.
RED BURN AREA ABOVE ELBOW (BELOW THE AREA OF VACCINE ADMINISTERED SITE OF MODERNA VACCINE)
Father stated that patient informed him on Friday, 08/23/2019 that left arm was big. He looked at it and agreed there was some swelling from left shoulder down to bicep, but thought this was a normal local reaction. On Saturday 08/24/2019, she had facial swelling and itching and so he took her to Urgent Care. He was instructed to give her Benadryl as needed and was also prescribed Prednisone 5mg/5ml oral solution. He brought her in to clinic 08/26/2019 after lunch and patient no longer presents with facial or arm swelling.
Site: Pain at Injection Site-Mild, Site: Redness at Injection Site-Severe, Site: Swelling at Injection Site-Severe, Systemic: Body Aches Generalized-Mild, Systemic: Exhaustion / Lethargy-Mild, Systemic: Fainting / Unresponsive-Mild, Systemic: Fever-Mild, Systemic: Headache-Medium, Systemic: Joint Pain-Mild, Systemic: Nausea-Mild, Additional Details: ***report is for flu shot, not covid*** forced me to select covid info
Pfizer 2/19/21, 3/12/21, 11/30/21. Positive on 11/21/22
She got her vaccine, she had no real reaction to it or sore arm.  She started having ringing in her ears and took her BP.  She put the cuff on below the injection site and that entire area got red and itched the next day after she took it BP.   This lasted for a couple of days and then went away.  The ringing in her ears was bad the reason for taking the BP, and was noticeably loud.  She has some tinnitus previous but nothing like she has now, she has constant loud ringing and has not diminished at all.  She has an APT with her PCP in 2 weeks to see about it.    She has looked on the internet and found that there are more people that have it, and this is something that she notices all the time and does not go away.  First thing in the morning it is noticeable and does not diminish in intensity throughout the day.  She said it more of a roaring than a hum.     She is conscious of it all the time.  When she had her first vaccine she traveled 2 weeks later and the alarms went off with the metal detector indicating that there was some sort of metal right below her injection site, but she was not wearing anything in that area.  There was also a signal around her neck, but she was wearing a necklace to explain that and wonders what that could have been.
Flu vaccine given on 8/14/15. Patient developed worsening pain over the next 2 weeks. Pain got to the point where patient could hardly move the arm the vaccine was given in. Tried Tylenol, Aleve, and a topical pain reliever with no relief.  Patient went to urgent care and was given prescription for prednisone and advised to take her Flexeril she already had at home. Condition improved but patient is still on the prednisone and Flexeril. Urgent care provider diagnosed patient with rotator cuff tendonitis and said it was due to flu shot.